Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the ...
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead ...
Tel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
No matter the market sentiment, gene editing is still a big deal for medical and pharmaceutical companies as well as patients and doctors. Two of the leading firms in the sector are CRISPR ...
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.